Doctors and patients surveyed on understanding of silent liver disease
NCT ID NCT07201831
Summary
This study was a survey to understand how much doctors, patients, and at-risk people know about a liver condition called MASH and its links to heart and kidney problems. Over 1,300 participants from five countries completed a 25-minute online questionnaire. The study did not test any treatments or collect lab data—it only gathered opinions and awareness levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novo Nordisk Investigational Site
Plainsboro, New Jersey, 08536, United States
-
Novo Nordisk Investigational Site
Mississauga, Canada
-
Novo Nordisk Investigational Site
Puteaux, France
-
Novo Nordisk Investigational Site
Mainz, Germany
-
Novo Nordisk Investigational Site
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.